Walvax Biotechnology (300142.SZ) released the quarterly report for the third quarter of 2024, with the company's revenue for the first three quarters at 2...
Zhixun Finance APP News, Walvax Biotechnology (300142.SZ) released the quarterly report for the third quarter of 2024, with the company's revenue for the first three quarters at 2.141 billion yuan, a decrease of 32.19% year-on-year. The net income attributable to shareholders of the listed company was 0.256 billion yuan, a decrease of 53.67% year-on-year. The net income attributable to shareholders of the listed company, excluding non-recurring gains and losses, was 0.224 billion yuan, a decrease of 59.84% year-on-year. The basic earnings per share was 0.1603 yuan.
